Viewing Study NCT02620020


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-03-02 @ 3:48 PM
Study NCT ID: NCT02620020
Status: COMPLETED
Last Update Posted: 2020-06-16
First Post: 2015-11-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Determine the Efficacy and Safety of Fasinumab for the Treatment of Adults With Chronic Low Back Pain
Sponsor: Regeneron Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-01-26
Start Date Type: ACTUAL
Primary Completion Date: 2017-02-03
Primary Completion Date Type: ACTUAL
Completion Date: 2017-09-13
Completion Date Type: ACTUAL
First Submit Date: 2015-11-30
First Submit QC Date: None
Study First Post Date: 2015-12-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-05-11
Results First Submit QC Date: None
Results First Post Date: 2019-08-01
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2018-02-08
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2020-06-08
Last Update Post Date: 2020-06-16
Last Update Post Date Type: ACTUAL